TÜV Rheinland at it-sa 2019: Cybersecurity through active defense

TÜV Rheinland: Hall 10.0, Stand 10.0-511 / Highlights: Operational Technology and expert certification / Appointments can now be made at www.tuv.com/it-sa-2019

TÜV Rheinland: Hall 10.0, Stand 10.0-511 / Highlights: Operational Technology and expert certification / Appointments can now be made at www.tuv.com/it-sa-2019

TÜV Rheinland: Operational Technology offers greater control and efficiencies – but what about the cybersecurity risk?

“Operational Technology“: Modern operational technology through connected machines / Many companies not aware of risks / For more information: https://www.tuv.com/cybersecurity-trends-2019

“Operational Technology“: Modern operational technology through connected machines / Many companies not aware of risks / For more information: https://www.tuv.com/cybersecurity-trends-2019

Gravel-proof

Wunderlich‘s complete undercarriage protection for the BMW F 850 GS and F 850 GS Adventure: Combination of »EXTREME« engine protection and the suitable centre stand protection plate. The centre stand protection plate is the consistent and logical addition to the Wunderlich »EXTREME« engine protection. The engine protection reliably protects the engine, manifold, front silencer and … „Gravel-proof“ weiterlesen

BayPAT’s Licensee Recardio already in Phase 2 Regenerative Post-Myocardial Infarction Trial of Dutogliptin in Europe and USA

BayPAT, a service provider offering services in the area of technology transfer, IP management and commercialisation, today announced that its licensee Recardio is already in the Phase 2 study for regenerative therapy in early recovery post-myocardial infarction in Europe and USA. The regenerative therapy concept of Recardio with its DPP-IV inhibitor dutogliptin is subject to … „BayPAT’s Licensee Recardio already in Phase 2 Regenerative Post-Myocardial Infarction Trial of Dutogliptin in Europe and USA“ weiterlesen

First Patients Enrolled into the MOCA I Trial

CorFlow Therapeutics AG ("CorFlow") today announced that the first two patients have been enrolled into the First-in-Man (FIM) MOCA I clinical trial.  The first MOCA (Microvascular Obstruction with the CoFITM System Assessment) trial is a safety and feasibility trial assessing the CorFlow Controlled Flow Infusion (CoFITM) System. In the first roll-in phase, non-acute (NSTEMI) patients will undergo microvascular … „First Patients Enrolled into the MOCA I Trial“ weiterlesen

TÜV Rheinland: Cybersecurity has become a board-level issue

Experts present study on Cybersecurity Trends 2019: Data protection and data security increasingly an issue for management / Representative survey in Germany: Four out of ten companies mandate employees to attend training courses

Experts present study on Cybersecurity Trends 2019: Data protection and data security increasingly an issue for management / Representative survey in Germany: Four out of ten companies mandate employees to attend training courses

TÜV Rheinland: Cyber Hazards for Operational Technology Underestimated

Study on cybersecurity in operational technology / Many companies are not aware of risks / Study can be downloaded at http://www.tuv.com/ot-security-us

Study on cybersecurity in operational technology / Many companies are not aware of risks / Study can be downloaded at http://www.tuv.com/ot-security-us

Immungenetics AG: Last Patient Last Visit (LPLV) reached in first part of the DrainAD Study, a Phase 2 trial for the early diagnosis and causative treatment of Alzheimer’s Disease (AD)

Immungenetics AG, a German based biopharmaceutical company focusing on novel treatments for unmet medical needs in the field of neurodegenerative, autoimmune diseases and aging, announced today that the last study visit of the last patient enrolled (Last Patient’s Last Visit, LPLV) occurred on 06 June 2018 in the first subgroup of DrainAD, a Phase II proof-of-concept study … „Immungenetics AG: Last Patient Last Visit (LPLV) reached in first part of the DrainAD Study, a Phase 2 trial for the early diagnosis and causative treatment of Alzheimer’s Disease (AD)“ weiterlesen

Cloud-based PrEstoCloud pilot manages huge data streams from video surveillance systems

PrEstoCloud is a research project funded by the European Commission with the goal of developing a dynamic and distributed software architecture platform that manages cloud and fog resources proactively, while utilizing edge resources for efficient real-time big data processing. Three pilot projects in different domains will demonstrate the power of PrEstoCloud’s new approach: wide-area video … „Cloud-based PrEstoCloud pilot manages huge data streams from video surveillance systems“ weiterlesen